These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38236081)

  • 1. Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery.
    Sunoqrot S; Abdel Gaber SA; Abujaber R; Al-Majawleh M; Talhouni S
    ACS Appl Bio Mater; 2024 Aug; 7(8):4998-5019. PubMed ID: 38236081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
    Neill B; Romero AR; Fenton OS
    ACS Appl Bio Mater; 2024 Aug; 7(8):4894-4913. PubMed ID: 37930174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanovaccines: An effective therapeutic approach for cancer therapy.
    Gurunathan S; Thangaraj P; Wang L; Cao Q; Kim JH
    Biomed Pharmacother; 2024 Jan; 170():115992. PubMed ID: 38070247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid/polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines.
    Beg S; Almalki WH; Khatoon F; Alharbi KS; Alghamdi S; Akhter MH; Khalilullah H; Baothman AA; Hafeez A; Rahman M; Akhter S; Choudhry H
    Drug Discov Today; 2021 Aug; 26(8):1891-1903. PubMed ID: 33610757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccine for cancer immunotherapy.
    Miao L; Zhang Y; Huang L
    Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node-targeting nanovaccines for cancer immunotherapy.
    Wang Q; Wang Z; Sun X; Jiang Q; Sun B; He Z; Zhang S; Luo C; Sun J
    J Control Release; 2022 Nov; 351():102-122. PubMed ID: 36115556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticle-based nanovaccines for cancer immunotherapy.
    Zhang Y; Chen J; Shi L; Ma F
    Mater Horiz; 2023 Feb; 10(2):361-392. PubMed ID: 36541078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Nanotechnology-Mediated Cancer Immunotherapy.
    Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J
    Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
    Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
    J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Nanovaccine Delivery in Cancer Immunotherapy.
    Zhu G; Zhang F; Ni Q; Niu G; Chen X
    ACS Nano; 2017 Mar; 11(3):2387-2392. PubMed ID: 28277646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy.
    Jahanafrooz Z; Oroojalian F; Mokhtarzadeh A; Rahdar A; Díez-Pascual AM
    Drug Dev Res; 2024 Aug; 85(5):e22244. PubMed ID: 39138855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges.
    Ahmad MZ; Ahmad J; Haque A; Alasmary MY; Abdel-Wahab BA; Akhter S
    Expert Rev Vaccines; 2020 Nov; 19(11):1053-1071. PubMed ID: 33315512
    [No Abstract]   [Full Text] [Related]  

  • 18. An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer.
    Lin Y; Chen X; Wang K; Liang L; Zhang H
    Vaccines (Basel); 2024 Jun; 12(7):. PubMed ID: 39066365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
    Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
    J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.